Product Details

Veropof is a sterile injectable emulsion that meets British Pharmacopoeia (BP) standards. Specifically, it delivers Propofol at 1% w/v for intravenous use in general anaesthesia. As a result, it offers a fast-onset, short-acting sedative-hypnotic agent for both induction and maintenance of anaesthesia.

The injection contains:

• Propofol BP (200mg per 20mL, 1% w/v emulsion) – A short-acting intravenous anaesthetic agent that enhances GABA-A receptor activity in the central nervous system. Consequently, it produces rapid, smooth induction of anaesthesia along with a quick, clear-headed recovery once administration stops.

Anaesthetists use Veropof for the induction and maintenance of general anaesthesia in adult and paediatric patients. In addition, its rapid onset and short duration make it suitable for sedation during diagnostic and surgical procedures. Because of this profile, Veropof suits operating theatres, ICUs, and day-care surgical units where controlled, titratable anaesthesia is essential.

Key Features:

• Overall, this BP-compliant formulation guarantees pharmaceutical-grade purity
• Additionally, the 1% w/v emulsion delivers a consistent, validated concentration in every vial
• Furthermore, the single-dose vial format minimizes contamination risk
• Notably, rigorous purity and sterility testing backs every stage of manufacturing
• Beyond that, light-protected packaging preserves emulsion stability during storage
• Ultimately, a reliable supply chain suits bulk distribution to hospitals, ICUs, and surgical centres